285 related articles for article (PubMed ID: 34909670)
41. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
42. An Overview on Promising Nanotechnological Approaches for the Treatment of Psoriasis.
Pandey K; Nimisha
Recent Pat Nanotechnol; 2020; 14(2):102-118. PubMed ID: 32013854
[TBL] [Abstract][Full Text] [Related]
43. Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
Mohammad Sadeghi H; Adeli I; Mousavi T; Daniali M; Nikfar S; Abdollahi M
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440518
[TBL] [Abstract][Full Text] [Related]
44. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ
Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159
[TBL] [Abstract][Full Text] [Related]
45. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
Chopra G; Samudrala R
Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
[TBL] [Abstract][Full Text] [Related]
46. Current Trends on Repurposing and Pharmacological Enhancement of Andrographolide.
Ren X; Xu W; Sun J; Dong B; Awala H; Wang L
Curr Med Chem; 2021; 28(12):2346-2368. PubMed ID: 32778020
[TBL] [Abstract][Full Text] [Related]
47. Repurposing Drugs to Target the Diabetes Epidemic.
Turner N; Zeng XY; Osborne B; Rogers S; Ye JM
Trends Pharmacol Sci; 2016 May; 37(5):379-389. PubMed ID: 26900045
[TBL] [Abstract][Full Text] [Related]
48. The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes.
Gendrisch F; Haarhaus B; Krieger N; Quirin KW; Schempp CM; Wölfle U
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801280
[TBL] [Abstract][Full Text] [Related]
49. A review of computational drug repurposing.
Park K
Transl Clin Pharmacol; 2019 Jun; 27(2):59-63. PubMed ID: 32055582
[TBL] [Abstract][Full Text] [Related]
50. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
51. Repurposing and repositioning neurosteroids in the treatment of traumatic brain injury: A report from the trenches.
Stein DG; Sayeed I
Neuropharmacology; 2019 Mar; 147():66-73. PubMed ID: 29630902
[TBL] [Abstract][Full Text] [Related]
52. Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.
Hall CJ; Wicker SM; Chien AT; Tromp A; Lawrence LM; Sun X; Krissansen GW; Crosier KE; Crosier PS
Dis Model Mech; 2014 Sep; 7(9):1069-81. PubMed ID: 25038060
[TBL] [Abstract][Full Text] [Related]
53. Drug repurposing in neurological diseases: an integrated approach to reduce trial and error.
Clout AE; Della Pasqua O; Hanna MG; Orlu M; Pitceathly RDS
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1270-1275. PubMed ID: 31171583
[TBL] [Abstract][Full Text] [Related]
54. Repurposing Drugs to Treat Heart and Brain Illness.
Cantrell MS; Soto-Avellaneda A; Wall JD; Ajeti AD; Morrison BE; Warner LR; McDougal OM
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208502
[TBL] [Abstract][Full Text] [Related]
55. Repurposing Drugs for Skin Cancer.
Khachigian LM
Curr Med Chem; 2020; 27(42):7214-7221. PubMed ID: 31858902
[TBL] [Abstract][Full Text] [Related]
56. Unlocking therapeutic potential: integration of drug repurposing and immunotherapy for various disease targeting.
Pawar VA; Tyagi A; Verma C; Sharma KP; Ansari S; Mani I; Srivastva SK; Shukla PK; Kumar A; Kumar V
Am J Transl Res; 2023; 15(8):4984-5006. PubMed ID: 37692967
[TBL] [Abstract][Full Text] [Related]
57. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Gelosa P; Castiglioni L; Camera M; Sironi L
Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
[TBL] [Abstract][Full Text] [Related]
58. Identification of novel analgesics through a drug repurposing strategy.
Gazerani P
Pain Manag; 2019 Jul; 9(4):399-415. PubMed ID: 30950770
[TBL] [Abstract][Full Text] [Related]
59. Old drugs for a new indication: a review of chloroquine and analogue in COVID-19 treatment.
Ehianeta TS; Akinyeye RO; Orege JI; Ejeromedoghene O; Adebule AP; Okonkwo BO
Porto Biomed J; 2021; 6(3):e132. PubMed ID: 34136717
[TBL] [Abstract][Full Text] [Related]
60. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
Fletcher JM; Moran B; Petrasca A; Smith CM
Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
